Topic Hub
15 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 15 of 15 clinical reviews.
Complete caregiver guide for giving Jatenzo (oral testosterone undecanoate) to adolescents aged 12 to 17, including dosing schedules, food requirements, missed-dose rules, and safety monitoring based on FDA labeling and clinical evidence.
Read clinical reviewA clinical guide for adolescents aged 12-17 taking Jatenzo (oral testosterone undecanoate) covering school schedules, meal timing, sports eligibility, and activity safety.
Read clinical reviewA clinical guide to transitioning adolescent males on Jatenzo (oral testosterone undecanoate) to adult care, covering dose titration, monitoring schedules, provider handoff protocols, and long-term safety data.
Read clinical reviewA clinician-focused guide to prescribing Jatenzo (oral testosterone undecanoate) in men aged 65 and older, covering dosing, cardiovascular monitoring, benefit-risk framing, and care-coordination principles for geriatric patients moving into or through adult outpatient settings.
Read clinical reviewA clinician-reviewed guide for caregivers helping adults 65 and older take Jatenzo (oral testosterone undecanoate) safely, covering dosing schedules, food requirements, cardiovascular monitoring, and fall-risk precautions.
Read clinical reviewA clinical guide for men 65 and older taking Jatenzo (oral testosterone undecanoate) covering physical activity safety, fall risk, cardiovascular monitoring, and daily scheduling around food requirements.
Read clinical reviewA clinician-reviewed guide to the developmental impact of Jatenzo (oral testosterone undecanoate) in adolescents aged 12 to 17, covering bone age, growth plate closure, pubertal staging, cardiovascular risk, and prescribing considerations.
Read clinical reviewA comprehensive clinical review of Jatenzo (oral testosterone undecanoate) off-label use in adolescents aged 12 to 17, covering evidence, dosing, safety monitoring, and when prescribers might consider it.
Read clinical reviewA comprehensive clinical review of Jatenzo (oral testosterone undecanoate) in geriatric patients aged 65+, covering pharmacokinetics, cardiovascular risk, bone and muscle outcomes, cognitive effects, and prescribing considerations for older men.
Read clinical reviewA clinician-reviewed guide to off-label Jatenzo (oral testosterone undecanoate) use in men 65 and older, covering cardiovascular risks, PSA monitoring, dosing, and what current guidelines actually say.
Read clinical reviewA clinical review of Jatenzo (oral testosterone undecanoate) use in pediatric patients under age 12, covering bone age advancement, hypothalamic-pituitary-gonadal axis suppression, growth plate risk, and FDA labeling guidance.
Read clinical reviewA detailed clinical review of Jatenzo (oral testosterone undecanoate) use in children under age 12, covering FDA approval status, risks of premature epiphyseal closure, alternative therapies, and the limited evidence base guiding off-label decisions.
Read clinical reviewA physician-reviewed guide for caregivers on Jatenzo (oral testosterone undecanoate) in children under 12, covering FDA labeling, dosing, administration steps, safety monitoring, and when to call the prescriber.
Read clinical reviewA clinician-reviewed guide covering how Jatenzo (oral testosterone undecanoate) affects school performance, physical activity, and daily routines in children under age 12, including dosing context, monitoring, and safety data.
Read clinical reviewA comprehensive clinical guide on transitioning pediatric patients under age 12 from Jatenzo (oral testosterone undecanoate) to adult hormone care, covering dosing, monitoring, safety, and guideline-based recommendations.
Read clinical review